arrow_back Civic Audit
Share share

Home Infusion Access: Medicare to Cover Pumps and Drugs

This act expands Medicare coverage to include external infusion pumps and non-self-administrable home infusion drugs. This means individuals requiring regular infusions can receive treatment in their own homes, potentially improving comfort and access to care. Patients will also be informed about the cost-sharing for home treatment compared to other options.
Key points
Medicare will cover external infusion pumps and associated home infusion drugs that require professional supervision.
Home treatment will be available for drugs administered intravenously or subcutaneously at least 12 times per year, or requiring an external infusion pump.
Patients will be notified of cost-sharing differences between home infusion therapy and other care settings.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_4993
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2025-08-19
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Joe Fiandra Access to Home Infusion Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4993.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-08-19.

What are the main provisions?

Key points include:

  • Medicare will cover external infusion pumps and associated home infusion drugs that require professional supervision.
  • Home treatment will be available for drugs administered intravenously or subcutaneously at least 12 times per year, or requiring an external infusion pump.
  • Patients will be notified of cost-sharing differences between home infusion therapy and other care settings.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fitzpatrick, Brian K. [R-PA-1].

What is the latest detailed status?

The latest detailed status is: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Benefits